The Clinical significance of STAT-PAT-PAK ULTRA FAST(R) and ICT Tuberculosis for Serologic Diagnosis of Tuberculosis.
10.4046/trd.1999.47.3.311
- Author:
Geun Hwa KIM
1
;
Hee Sun PARK
;
Myung Hoon KIM
;
Dong Won KANG
;
Gyu Seung LEE
;
Dong Seok KO
;
Jae Chul SUH
;
Seong Su JEONG
;
Ju Ock KIM
;
Sun Young KIM
Author Information
1. Department of Internal Medicine, College of medicine Chungnam National University, Taejon, Korea. jokim@haubat.chungnam.ac.kr
- Publication Type:Original Article
- Keywords:
STAT-PAK ULTRA FAST(R);
ICT Tuberculosis;
Tuberculosis;
Serologic diagnosis
- MeSH:
Developing Countries;
Diagnosis*;
Diagnosis, Differential;
Humans;
Immunodominant Epitopes;
Lung Diseases;
Mycobacterium tuberculosis;
Tuberculosis*;
Tuberculosis, Pulmonary
- From:Tuberculosis and Respiratory Diseases
1999;47(3):311-320
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: In recent years, tuberculosis has re-emerged as a major health problem in both industrialized and developing countries. Recent advances in identifying and purifying antigens secreted in active tuberculosis infection have lead to the development of serological assays based on a number of immunodominant antigens. To date, the most sensitive and specific of these antigens has been the 38-kDa antigen. METHOD: Two rapid membrane-based serologic assays using antigen(38-kDa) from mycobacterium tuberculosis for the diagnosis of tuberculosis were evaluated in 22 patients with smear-positive pulmonary tuberculosis, 14 patients with inactive pulmonary tuberculosis, and 9 patients with non-tuberculous lung disease. RESULT: The evaluation of validity(sensitivity, specificity, positive predictive value, negative predictive value, false positivity and false negativity) of STAT-PAK ULTRA FAST(R) were 77.3%, 28.6%, 63.0%, 44.4%, 71.4%, and 22.7% for differential diagnosis of active pulmonary tuberculosis and inactive pulmonary tuberculosis, respectively. The evaluation of validity of STAT-PAK ULTRA FAST(R) were 77.3%, 33.3%, 73.9%, 37.5%, 66.7%, and 22.7% for differential diagnosis of active pulmonary tuberculosis and non-tuberculosis. The evaluation of validity of ICT Tuberculosis were 54.5%, 57%, 66.7%, 44.4%, 42.9%, and 45.5% for differential diagnosis of active pulmonary tuberculosis and inactive pulmonary tuberculosis. The evaluation of validity of ICT Tuberculosis were 54.5%, 100%, 100%, 47.4%, 0%, and 45.4% for differential diagnosis of active pulmonary tuberculosis and non-tuberculosis. CONCLUSION: We concluded no effectiveness of STAT-PAK ULTRA FAST(R) and ICT tuberculosis on serologic diagnosis of pulmonary tuberculosis. In the future, further large-scale study should be needed for serologic diagnosis of pulmonary tuberculosis.
